Johnson & Johnson logo

Johnson & Johnson JNJ

$ 162.37 1.68%

Annual report 2024
added 02-13-2025

report update icon

Country

usaUSA

IPO year

-

Industry

Drug manufacturers

Stock Exchange

NYSESPB

CEO

Mr. Alex Gorsky

Employees in the company

132 200

Shares

2.41 B

Market Cap[1]

$ 391 B

EBITDA (LTM)

$ 9.42 B

P/E (LTM)

11.25

P/S (LTM)

4.79

EPS (LTM)

14.74

Johnson & Johnson is a multinational corporation that specializes in healthcare products, medical devices, and pharmaceuticals. Founded in 1886, the company has grown to become one of the largest healthcare companies in the world, with operations in over 60 countries.

The company's products are used by millions of people every day, from baby shampoo and band-aids to prescription drugs and surgical equipment. Some of its most well-known brands include Tylenol, Neutrogena, and Listerine.

Johnson & Johnson is committed to improving the health and well-being of people around the world. The company invests heavily in research and development, with a focus on finding new treatments for diseases such as cancer, Alzheimer's, and HIV/AIDS.

In addition to its healthcare products, Johnson & Johnson is also known for its commitment to corporate social responsibility. The company has a long history of supporting various charitable causes, including disaster relief efforts and global health initiatives.

Overall, is a trusted and respected leader in the healthcare industry, with a strong track record of innovation and social responsibility.

Other stocks of industry "Drug manufacturers"

Issuer Price % 24h Market Cap Exchange Country
Collegium Pharmaceutical Collegium Pharmaceutical
COLL
$ 29.44 -1.04 % $ 951 M Nasdaq Global Select Market usaUSA
Amryt Pharma plc Amryt Pharma plc
AMYT
$ 14.7 - $ 621 M Nasdaq Global Select Market britainBritain
Aerie Pharmaceuticals Aerie Pharmaceuticals
AERI
$ 15.25 - $ 754 M Nasdaq Global Market,SPB usaUSA
PetIQ PetIQ
PETQ
$ 13.6 1.64 % $ 400 M Nasdaq Global Select Market,SPB usaUSA
Agile Therapeutics Agile Therapeutics
AGRX
$ 0.6 10.11 % $ 58.2 M Nasdaq Capital Market usaUSA
Teligent, Inc. Teligent, Inc.
TLGT
$ 0.173 -13.85 % $ 16.1 M Nasdaq Global Select Market usaUSA
Recro Pharma Recro Pharma
REPH
$ 1.4 -4.76 % $ 65.3 M Nasdaq Global Select Market usaUSA
Athenex Athenex
ATNX
$ 0.2 -23.39 % $ 1.76 M Nasdaq Global Select Market usaUSA
PLx Pharma PLx Pharma
PLXP
$ 0.09 -27.8 % $ 2.56 M Nasdaq Capital Market usaUSA
Shineco, Inc. Shineco, Inc.
TYHT
$ 11.09 -3.90 % $ 97.2 M Nasdaq Global Select Market chinaChina
Ironwood Pharmaceuticals Ironwood Pharmaceuticals
IRWD
$ 1.81 -4.74 % $ 281 M Nasdaq Global Select Market usaUSA
Organogenesis Holdings Organogenesis Holdings
ORGO
$ 3.23 -4.59 % $ 424 M Nasdaq Capital Market usaUSA
Lannett Company Lannett Company
LCI
$ 0.66 1.15 % $ 7.11 M NYSE usaUSA
DURECT Corporation DURECT Corporation
DRRX
$ 0.78 -3.16 % $ 20.5 M Nasdaq Capital Market usaUSA
Biogen Biogen
BIIB
$ 141.07 2.91 % $ 20.5 B Nasdaq Global Select Market,SPB usaUSA
Calliditas Therapeutics AB (publ) Calliditas Therapeutics AB (publ)
CALT
$ 40.0 -0.1 % $ 2.03 B Nasdaq Global Select Market schwedenSchweden
GW Pharmaceuticals plc GW Pharmaceuticals plc
GWPH
$ 218.96 - $ 6.81 B Nasdaq Global Select Market britainBritain
Adamas Pharmaceuticals, Inc. Adamas Pharmaceuticals, Inc.
ADMS
$ 8.22 - $ 376 M Nasdaq Global Market usaUSA
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc.
FLXN
$ 9.12 - $ 459 M Nasdaq Global Market usaUSA
Sonoma Pharmaceuticals Sonoma Pharmaceuticals
SNOA
$ 2.41 -0.27 % $ 21.9 M Nasdaq Capital Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.